Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Uterine Cervical Neoplasms × selinexor × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 17 Recurrence 6 Lymphoma, Large B-Cell, Diffuse 6 Leukemia, Myeloid, Acute 5 Sarcoma 3 Neurofibrosarcoma 3 Primary Myelofibrosis 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Glioblastoma 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Vascular Neoplasms 1 Triple Negative Breast Neoplasms 1 Solitary Fibrous Tumors 1 Smooth Muscle Tumor 1 Sarcoma, Endometrial Stromal 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Salivary Gland Neoplasms 1 Rhabdoid Tumor 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Osteosarcoma 1 Nerve Sheath Neoplasms 1 Neoplasms, Adipose Tissue 1 Neoplasms 1 Neoplasm Metastasis 1 Myoepithelioma 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1

Interventions

pembrolizumab 31 Cisplatin 28 Carboplatin 15 Radiotherapy 14 Paclitaxel 14 Bevacizumab 14 Brachytherapy 13 Colposcopy 11 Specimen Handling 10 Nivolumab 10 Blood Specimen Collection 10 Gemcitabine 9 Radiation 8 Magnetic Resonance Spectroscopy 8 Human Papillomavirus DNA Tests 8 Drug Therapy 8 lenvatinib 6 atezolizumab 6 Platinum 6 dostarlimab 5 Radiotherapy, Intensity-Modulated 5 Methods 5 Biopsy 5 1,2-diaminocyclohexaneplatinum II citrate 5 zimberelimab 4 toripalimab 4 spartalizumab 4 Topotecan 4 Restraint, Physical 4 Pemetrexed 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡